NOX1 is also critical for the development of experimental HCC following the treatment of rodents with diethylnitrosamine (DEN); thus, the pharmacological inhibition of NOX1 attenuated hepatocarcinogenesis by mitigating inflammatory, angiogenic and fibrogenic responses [209]. The gene discussed is NOX1; the disease is hepatocellular carcinoma.